The shifting paradigm in the treatment of type 2 diabetes mellitus-A cardiologist's perspective

被引:1
作者
Fatima, Saeeda [1 ]
Jameel, Ayesha [1 ]
Ayesha, F. N. U. [2 ]
Menzies, Dhananjai J. [3 ]
机构
[1] Bassett Med Ctr, Dept Internal Med, New York, NY USA
[2] Serv Inst Med Sci, Dept Internal Med, Lahore, Pakistan
[3] Bassett Med Ctr, Intervent Cardiol & Catheterizat Labs, New York, NY USA
关键词
Cardiovascular Risk; Cardiovascular Safety; Novel Antiglycemic Drugs; Type 2 Diabetes Mellitus; CARDIOVASCULAR OUTCOMES; MACROVASCULAR DISEASE; AMERICAN-COLLEGE; METFORMIN; RISK; MORTALITY; INSULIN; LIRAGLUTIDE; ASSOCIATION; PREVENTION;
D O I
10.1002/clc.22781
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In patients with diabetes mellitus, cardiovascular (CV) disease is the leading cause of morbidity and mortality. A multitude of contemporary antidiabetic agents presents different CV safety profiles. Metformin forms the cornerstone agent to reduce CV events. Newer agents, such as glucagon-like peptide-1 agonists and sodium-glucose cotransporter-2 inhibitors, have appealing CV benefits. Insulin, dipeptidyl peptidase-4 inhibitors, and sulfonylureas have neutral CV effects. Cardiologists should familiarize themselves with these agents to promote comprehensive CV care in patients with diabetes mellitus.
引用
收藏
页码:970 / 973
页数:4
相关论文
共 50 条
[41]   Cardiovascular risk reduction in older people with type 2 diabetes mellitus-a comprehensive narrative review [J].
Si, Pann Ei Hnynn ;
Parker, S. ;
Abdelhafiz, D. ;
Summerbell, A. ;
Muzulu, S. ;
Abdelhafiz, Ahmed H. .
DIABETES RESEARCH AND CLINICAL PRACTICE, 2024, 211
[42]   Clinical and Pharmacotherapeutic Profile of Patients with Type 2 Diabetes Mellitus Admitted to a Hospital Emergency Department [J].
Lopes, Antonio Cabral ;
Lourenco, Olga ;
Roque, Fatima ;
Morgado, Manuel .
BIOMEDICINES, 2023, 11 (02)
[43]   Type 2 diabetes mellitus: cardiovascular risk and cardiac rehabilitation concerns. Part I [J].
Perez Yanez, C. Lazara M. ;
Gutierrez Lopez, Alain ;
Rodriguez Blanco, Suilbert .
CORSALUD, 2021, 13 (02) :217-228
[44]   Diabetes in Pregnancy - Type 1/Type 2 Diabetes Mellitus and Gestational Diabetes Mellitus [J].
Kleinwechter, Helmut ;
Demandt, Norbert .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2016, 141 (18) :1296-+
[45]   Coffee consumption and type 2 diabetes mellitus [J].
Radzeviciene, Lina ;
Ostrauskas, Rytas .
MEDICINA-LITHUANIA, 2009, 45 (01) :61-67
[46]   Association of menopause and type 2 diabetes mellitus [J].
Ren, Yongcheng ;
Zhang, Ming ;
Liu, Yu ;
Sun, Xizhuo ;
Wang, Bingyuan ;
Zhao, Yang ;
Liu, Dechen ;
Liu, Xuejiao ;
Zhang, Dongdong ;
Liu, Feiyan ;
Cheng, Cheng ;
Liu, Leilei ;
Chen, Xu ;
Zhou, Qionggui ;
Hu, Dongsheng .
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2019, 26 (03) :325-330
[47]   Swiss recommendations of the Society for Endocrinology and Diabetes (SGED/SSED) for the treatment of type 2 diabetes mellitus (2023) [J].
Gastaldi, Giacomo ;
Lucchini, Barbara ;
Thalmann, Sebastien ;
Alder, Stephanie ;
Laimer, Markus ;
Braendle, Michael ;
Wiesli, Peter ;
Lehmann, Roger .
SWISS MEDICAL WEEKLY, 2023, 153
[48]   Incretin Therapy for Type 2 Diabetes Mellitus [J].
Klonoff, David C. .
ADVANCES IN THERAPY, 2010, 27 (12) :881-894
[49]   Vitamin D and type 2 diabetes mellitus [J].
Cangoz, S. ;
Chang, Y. -Y. ;
Chempakaseril, S. J. ;
Guduru, R. C. ;
Huynh, L. M. ;
John, J. S. ;
John, S. T. ;
Joseph, M. E. ;
Judge, R. ;
Kimmey, R. ;
Kudratov, K. ;
Lee, P. J. ;
Madhani, I. C. ;
Shim, P. J. ;
Singh, S. ;
Singh, S. ;
Ruchalski, C. ;
Raffa, R. B. .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2013, 38 (02) :81-84
[50]   Relationship of the Serum CRP Level With the Efficacy of Metformin in the Treatment of Type 2 Diabetes Mellitus: A Meta-Analysis [J].
Shi, Lei ;
Tan, Guang-Shan ;
Zhang, Kun .
JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2016, 30 (01) :13-22